Inogen | INGN - Loan Capital


Inogen reported $0 in Loan Capital for its fiscal quarter ending in June of 2022.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
Accuray USD 127.32M 3.53M Sep/2025
AngioDynamics USD 5.9M 5.9M Feb/2025
Artivion USD 214.87M 669K Sep/2025
AtriCure USD 61.86M 0 Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Boston Scientific USD 10.99B 12M Sep/2025
Chart Industries USD 3.57B 84.3M Dec/2025
Cooper Companies USD 2.46B 26.1M Sep/2025
Dexcom USD 1.24B 53.6M Dec/2025
Edwards Lifesciences USD 598.2M 200K Sep/2025
Globus Medical USD 436K 9K Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 930.8M 4.1M Dec/2025
Masimo USD 518M 41.1M Dec/2025
Medtronic USD 27.62B 1.45B Sep/2025
Orthofix International USD 157.22M 172K Sep/2025
Philips EUR 6.93B 303M Dec/2025
ResMed USD 403.92M 4.74M Dec/2025
Steris USD 1.9B 1.1M Dec/2025
Stryker USD 14.86B 14M Dec/2025
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
X T L Biopharmaceuticals USD 0 0 Dec/2024
Zimmer Biomet Holdings USD 6.93B 580.6M Dec/2025